12 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

28 November 2024

Cancer Genetics Research

More gene testing means safer medication

31 October 2024

Pharmaceuticals Sarcoidosis

What we neglect in sarcoidosis care

17 October 2024

Pharmaceuticals Rare cancers

Breast cancer drug also work for appendiceal cancer

5 September 2024

PBS Pharmaceuticals

Expanded PBS listing for cabozantinib

5 September 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

22 August 2024

Pain Pharmaceuticals

Choice of first opioid predicts long-term use

27 June 2024

Pharmaceuticals Systems

Weight-based pembrolizumab gives more bang for the public buck

13 June 2024

Diabetes PBS Pharmaceuticals Political

PBS rejigs rules on GLP-1s and other diabetes meds

30 May 2024

Pain Pharmaceuticals

Opioids on the silver screen

7 March 2024

Pharmaceuticals Shortages

Oral morphine substitute approved

7 March 2024

Opinion Pharmaceuticals Technology

Our top 30 most valuable healthtech companies

8 February 2024

Immunotherapy Melanoma & skin cancer PBS Pharmaceuticals

Melanoma drug newly listed on PBS

6 September 2023

TGA TheHill

TGA’s plan to tackle drug shortage

6 September 2023

Colorectal cancer Lung cancer

New KRAS drug even better

26 July 2023

Drugs Gastrointestinal cancer Research

Success for second-line therapy in gastric cancers

12 July 2023

TGA

Peak health bodies unite to fight drug discontinuation

31 May 2023

Digital Health Treatment

Time’s up for online prescription mills

17 May 2023

Drugs TGA

The legacy of John Skerritt

3 May 2023

Lung cancer

Lung cancer survival higher in SGLT2 users